Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DP-VPA for Migraine Prophylaxis
NCT00640965Phase 2Withdrawn
- Sponsor
- D-Pharm
- Start
- Jul 2008
- Primary completion
- Jun 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DP-VPA in migraine, sponsored by D-Pharm. Planned start Jul 2008; status: withdrawn.
02
Drugs
DP-VPA
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00640965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640965.